A modified risk assessment scoring system for post laser in situ keratomileusis ectasia in topographically normal patients

针对角膜地形图正常的患者,对激光原位角膜磨镶术后扩张进行改良的风险评估评分系统

阅读:1

Abstract

PURPOSE: To evaluate and modify the Randleman Ectasia Risk Score System for predicting post-laser in situ keratomileusis (LASIK) ectasia in patients with normal preoperative corneal topography. METHODS: In this retrospective study we reviewed data from 136 eyes which had undergone LASIK including 34 ectatic and 102 normal eyes between 1999 and 2009. After determining the sensitivity and specificity of the Randleman system, a modified model was designed to predict the risk of post-LASIK corneal ectasia more accurately. Next, the sensitivity and specificity of this modified scoring system was determined and compared to that of the original scoring system. RESULTS: In our sample, the sensitivity and specificity of the Randleman system was 70.1% and 50.5%, respectively. Our modified model included the following parameters: preoperative central corneal thickness, manifest refraction spherical equivalent, and maximum keratometry, as well as the number of months elapsed from surgery. Sensitivity and specificity rates of the modified system were 74.2% and 76.2%, respectively. The difference in receiver operating characteristic curves between the Randleman and modified scoring systems was statistically significant (P<0.001). The best sensitivity and specificity for our model occurred with a cumulative cutoff score of 4.00; a low risk was considered if the score was ≤4.00, and high risk was defined with a score > 4.00. CONCLUSION: Our modified ectasia risk scoring system for patients with normal corneal topography can predict post LASIK ectasia risk with acceptable sensitivity and specificity. However, there are still unidentified risk factors for which further studies are required.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。